More extracranial tumours had CD8+ T-cells, with 24% of samples having at least 10% (median = 5%; range 0–32%) of the immune infiltrating cells predicted to be CD8+ T-cells (Fig. 1d). The gene discussed is CD8A; the disease is neoplasm.